Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
Follow-Up Questions
Quelle est la performance du prix de l'action IMMB ?
Le prix actuel de IMMB est de $0.0001, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Immunotech Laboratories Inc ?
Immunotech Laboratories Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quel est la capitalisation boursière de Immunotech Laboratories Inc ?
La capitalisation boursière actuelle de Immunotech Laboratories Inc est de $57.4K
